Meneldor
About Meneldor
Meneldor offers her customers the unique opportunity to co-invest alongside specialists, in exciting early stage Biotech and Pharma companies. A sector often considered as very risky and highly complex. Meneldor thoroughly studies the science behind her potential portfolio companies. If the science is sound, then all other key aspects; IP, medical need, addressable markets, competition, risk, management, financial needs, valuation, etc., are assessed. Only if a target company meets our selection criteria, Meneldor will invest and invite her co-investors to participate.
In the news
Investment focus
Similar investors
Firms with overlapping sectors, stage and geography.
Keep going
Investor focus, stage and check size change often. Confirm current details on Meneldor's own website (meneldor.nl) before reaching out. Listing does not imply endorsement or any relationship.